News
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...
In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School ...
The AI tool, named “Pythia,” predicts how cells repair their DNA after CRISPR editing and opens the door to next-generation gene therapies.
1d
Zacks Investment Research on MSNCan Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?
CRISPR Therapeutics’ CRSP Casgevy, a one-shot gene therapy, was approved in late 2023 and early 2024 across the United States ...
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...
TB, a one-sample, parallelized reaction amplification and detection CRISPR assay that detects Mycobacterium tuberculosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results